Effect of Ledipasvir and Sofosbuvir on Proteinuria and Estimated Glomerular Filtration Rate in Patients With Early Stage (1-3) Hepatitis C Associated Chronic Kidney Disease
Phase of Trial: Phase IV
Latest Information Update: 14 Jul 2017
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Pharmacodynamics
- 11 Jul 2017 Planned primary completion date changed from 1 Apr 2017 to 31 Dec 2017.
- 10 Jun 2017 Biomarkers information updated
- 21 Oct 2016 Planned End Date changed from 1 Jul 2017 to 1 Apr 2018.